Skip to main content

Together we are beating cancer

Donate now

The Institute of Cancer Research

Showing 6 out of 6 results
Sample bottles in a lab

A spit test that predicts people's genetic risk of prostate cancer could help find more cases earlier, according to the BARCODE 1 trial. A spit test that predicts people's genetic risk of prostate cancer could help find more cases earlier, according to the BARCODE 1 trial.

by Tim Gunn | News | 1 June 2024

1 June 2024

Prostate Cancer cell image taken using a Scanning Electron Microscope

Research published in Cell Genomics today has shown that prostate cancer, which affects one in six men in the UK in their lifetime, includes two different subtypes of the disease, also known as evotypes. Research published in Cell Genomics today has shown that prostate cancer, which affects one in six men in the UK in their lifetime, includes two different subtypes of the disease, also known as evotypes.

by Amy Warnock | News | 29 February 2024

29 February 2024

Breast magnetic resonance image, or MRI. The bright white dot in the larger images is stage one breast cancer.

New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective New research from the ICR is showing us how additional measurements taken by MRI could speed up the development of new drugs that could make chemotherapies more effective

by Jacob Smith | Analysis | 9 May 2023

9 May 2023

Breast cancer screening

Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding. Cancer Research UK-funded scientists are using innovative techniques to understand how resistance to a targeted cancer drug is unfolding.

by Lilly Matson | Analysis | 10 January 2022

10 January 2022

prostate cancer biopsy
  • Science & Technology
  • Health & Medicine

Targeted prostate cancer screening: Are we there yet?

Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet? Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet?

by Katie Roberts | Analysis | 20 October 2021

20 October 2021

Prostate cancer cells
  • Science & Technology
  • Health & Medicine

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference. Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference.

by Cancer Research UK | News | 19 September 2021

19 September 2021